General Information


DRACP ID  DRACP04721

Peptide Name  

Sequence  RWRWRWRW

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C68H90N24O9

Absent amino acids  ACDEFGHIKLMNPQSTVY

Common amino acids  RW

Mass  151264

Pl  12.98

Basic residues  4

Acidic residues  0

Hydrophobic residues  4

Net charge  4

Boman Index  -5036

Hydrophobicity  -270

Aliphatic Index  0

Half Life 
  Mammalian: 0.8 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  22000

Absorbance 280nm  3142.86

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23301519

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 23203110

Title  Not available

Doi Not available

Year  Not available

Literature 3

Pubmed ID 20347875

Title  Not available

Doi Not available

Year  Not available

Literature 4

Pubmed ID 17145799

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  3161

CancerPPD ID  3162

CancerPPD ID  3163

CancerPPD ID  3164

DBAASP ID  261

DRACP is developed by Dr.Zheng's team.